Controlled, open, parallel-group study of the clinical and microbiological efficacy of piperacillin-tazobactam versus metronidazole + gentamicin in urgent colorectal surgery;Estudio controlado con grupos paralelos y abierto de la eficacia clínica y microbiológica de piperacilina-tazobactam frente a metronidazol más gentamicina en cirugía colorrectal urgente

Cirugia Espanola

Volumn 79, Issue 6, 2006, Pages 365-369

  Ferrer, Joana ^a,c   Fondevila, Constantino ^a   Bombuy, Ernest ^a   Fuster, Josep ^a   Álvarez, Guillermo ^b   Charco, Ramón ^a   García Valdecasas, Juan Carlos ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b Grupo Christus Muguerza   (Mexico)

^c C/ Villarroel   (Spain)

Author keywords

Antibiotic prophylaxis; Bacterial infections; Colorectal surgery; Combined antibiotics

Indexed keywords

ANTIINFECTIVE AGENT; DRUG DERIVATIVE; METRONIDAZOLE; PENICILLANIC ACID; PIPERACILLIN; PIPERACILLIN TAZOBACTAM COMBINATION PRODUCT; PIPERACILLIN-TAZOBACTAM COMBINATION PRODUCT;

ACUTE DISEASE; ADULT; APPENDICITIS; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG COMBINATION; EMERGENCY TREATMENT; FEMALE; HUMAN; MALE; METHODOLOGY; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL; SURGICAL INFECTION;

ACUTE DISEASE; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; APPENDICITIS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EMERGENCY TREATMENT; FEMALE; HUMANS; MALE; METRONIDAZOLE; PENICILLANIC ACID; PIPERACILLIN; SURGICAL WOUND INFECTION;

EID: 33748543243     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(06)70892-2     Document Type: Article

References (24)

1. Schein M, Assalia A, Bachus H. Minimal antibiotic therapy after emergency abdominal surgery: a prospective study. Br J Surg. 1994;81:989-91.
2. Rocha L, Azanza JR, Balibrea JL, Cainzos M, Garcia-Rodriguez JA, Gomis M, et al. Pautas de tratamiento antibiótico empírico de las infecciones intraabdominales. Rev Esp Quimioter. 2000;13:65-72.
3. Polk HC, Christmas AB. Prophylactic antibiotics in surgery and surgical wounds infections. Am Surg. 2000;66:105-11.
4. Koperna T, Schulz F. Relaparotomy in peritonitis: prognosis and treatment of patients with persisting intraabdominal infection. World J Surg. 2000;24:32-7.
5. Nyström PO. Transition from contamination to infection: implications in colonic surgery. Eur J Surg Supl. 1996;576:42-6.
6. Palomar M, Serra J. Infección postquirúrgica en pacientes graves. Enferm Infecc Microbiol Clin. 1997;15 Supl 3:20-6.
7. Mosdell DM, Morris DM, Voltura A, Pitcher DE, Twiest MW, Milne RL, et al. Antibiotic treatment for surgical peritonitis. Ann Surg. 1991;214:543-9.
8. Wilson SE, Faulkner K. Impact of anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections. Am Surg. 1998;64:402-7.
9. Isbister WH, Prasad J. Emergency large bowel surgery: a 15-year audit. Int J Colorectal Dis. 1997;12:285-90.
10. Bohnen JM. Antibiotic therapy for abdominal infection. World J Surg. 1998;22:152-7.
11. Lewis RT. Oral versus systemic antibiotic prophylaxis in elective colon surgery: a randomized study and meta-analysis send a message from the 1990s. Can J Surg. 2002;45:173-80.
12. Powell LL, Wilson SE. The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection. Surg Infect (Larchmt). 2000;1:57-63.
13. Raymond DP, Kuehnert MJ, Sawyer RG. Preventing antimicrobialresistant bacterial infections in surgical patients. Surg Infect (Larchmt). 2002;3:375-85.
14. Gorecki P, Schein M, Rucinski JC, Wise L. Antibiotic administration in patients undergoing common surgical procedures in a community teaching hospital: the chaos continues [discussion 433]. World J Surg. 1999;23:429-32.
15. Page CP, Bohnen JMA, Flechter JR, McManus AT, Solomkin JS, Wittmann DH. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg. 1993;128:79-88.
16. Condon RE. Microbiology of intraabdominal infection and contamination. Eur J Surg Suppl. 1996;576:9-12.
17. Jaccard C, Troillet N, Harbarth S, Zanetti G, Aymon D, Schneider R, et al. Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis. Antimicrob Agents Chemother. 1998;42:2966-72.
18. Cheadle WG, Spain DA. The continuing challenge of intra-abdominal infection [discussion 31S-34S]. Am J Surg. 2003;186:15S-22S.
19. Teppler H, Meibohm AR, Woods GL. Management of complicated appendicitis and comparison of outcome with other primary sites of intra-abdominal infection: results of a trial comparing ertapenem and piperacillin-tazobactam. J Chemother. 2004;16:62-9.
20. Yellin AE, Hassett JM, Fernandez A, Geib J, Adeyi B, Woods GL, et al; 004 Intra-abdominal Infection Study Group. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults. Int J Antimicrob Agents. 2002;20:165-73.
21. Christou NV, Barie PS, Dellinger EP, Waymack JP, Stone HH. Surgical infection Society intra-abdominal infection study. Prospective evaluation of management techniques and outcome [discussion 198-9]. Arch Surg. 1993;128:193-8.
22. Pacelli F, Doglietto GB, Alfieri S, Piccioni E, Sgadari A, Gui D, et al. Prognosis in intraabdominal infections. Multivariate analysis on 604 patients. Arch Surg. 1996;131:641-5.
23. Teppler H, Mc Carroll K, Gesser RM, Woods GL. Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam. Surg Infect (Larchmt). 2002 Winter; 3:337-49.
24. Solomkin JS, Yellin AE, Rotstein OD, Christou NV, Dellinger EP, Tellado JM, et al. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Results of a double-blind, randomized comparative phase III trial. Ann Surg. 2003;237:235-45.